BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35313355)

  • 1. Dusp26 phosphatase regulates mitochondrial respiration and oxidative stress and protects neuronal cell death.
    Eroglu B; Jin X; Deane S; Öztürk B; Ross OA; Moskophidis D; Mivechi NF
    Cell Mol Life Sci; 2022 Mar; 79(4):198. PubMed ID: 35313355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DUSP26 negatively affects the proliferation of epithelial cells, an effect not mediated by dephosphorylation of MAPKs.
    Patterson KI; Brummer T; Daly RJ; O'Brien PM
    Biochim Biophys Acta; 2010 Sep; 1803(9):1003-12. PubMed ID: 20347885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IDH2 deficiency promotes mitochondrial dysfunction and dopaminergic neurotoxicity: implications for Parkinson's disease.
    Kim H; Kim SH; Cha H; Kim SR; Lee JH; Park JW
    Free Radic Res; 2016 Aug; 50(8):853-60. PubMed ID: 27142242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
    Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
    Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSC-87877 inhibits DUSP26 function in neuroblastoma resulting in p53-mediated apoptosis.
    Shi Y; Ma IT; Patel RH; Shang X; Chen Z; Zhao Y; Cheng J; Fan Y; Rojas Y; Barbieri E; Chen Z; Yu Y; Jin J; Kim ES; Shohet JM; Vasudevan SA; Yang J
    Cell Death Dis; 2015 Aug; 6(8):e1841. PubMed ID: 26247726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual-Specificity Phosphatase 26 Protects Against Cardiac Hypertrophy Through TAK1.
    Zhao J; Jiang X; Liu J; Ye P; Jiang L; Chen M; Xia J
    J Am Heart Assoc; 2021 Feb; 10(4):e014311. PubMed ID: 33522247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-specificity phosphatase 26-dificient neurons are susceptible to oxygen-glucose deprivation/reoxygenation-evoked apoptosis and proinflammatory response by affecting the TAK1-medaited JNK/P38 MAPK pathway.
    Zhao H; Lv J; Meng L; Lv J; Li Z
    Int Immunopharmacol; 2023 Apr; 117():109980. PubMed ID: 37012870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
    Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
    Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review of DUSP26: Structure, Regulation and Relevance in Human Disease.
    Thompson EM; Stoker AW
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33466673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual-specificity phosphatase 26 (DUSP26) stimulates Aβ42 generation by promoting amyloid precursor protein axonal transport during hypoxia.
    Jung S; Nah J; Han J; Choi SG; Kim H; Park J; Pyo HK; Jung YK
    J Neurochem; 2016 Jun; 137(5):770-81. PubMed ID: 26924229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DUSP26 phosphatase activator adenylate kinase 2 regulates FADD phosphorylation and cell growth.
    Kim H; Lee HJ; Oh Y; Choi SG; Hong SH; Kim HJ; Lee SY; Choi JW; Su Hwang D; Kim KS; Kim HJ; Zhang J; Youn HJ; Noh DY; Jung YK
    Nat Commun; 2014; 5():3351. PubMed ID: 24548998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
    Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
    Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction.
    Kao CY; Xu M; Wang L; Lin SC; Lee HJ; Duraine L; Bellen HJ; Goldstein DS; Tsai SY; Tsai MJ
    PLoS Genet; 2020 Jun; 16(6):e1008868. PubMed ID: 32579581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-specificity phosphatase 26 is a novel p53 phosphatase and inhibits p53 tumor suppressor functions in human neuroblastoma.
    Shang X; Vasudevan SA; Yu Y; Ge N; Ludwig AD; Wesson CL; Wang K; Burlingame SM; Zhao YJ; Rao PH; Lu X; Russell HV; Okcu MF; Hicks MJ; Shohet JM; Donehower LA; Nuchtern JG; Yang J
    Oncogene; 2010 Sep; 29(35):4938-46. PubMed ID: 20562916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons.
    Jiang H; Kang SU; Zhang S; Karuppagounder S; Xu J; Lee YK; Kang BG; Lee Y; Zhang J; Pletnikova O; Troncoso JC; Pirooznia S; Andrabi SA; Dawson VL; Dawson TM
    eNeuro; 2016; 3(4):. PubMed ID: 27622213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of DJ-1 function contributes to Parkinson's disease pathogenesis in mice via RACK1-mediated PKC activation and MAO-B upregulation.
    Liu LL; Han Y; Zhang ZJ; Wang YQ; Hu YW; Kaznacheyeva E; Ding JQ; Guo DK; Wang GH; Li B; Ren HG
    Acta Pharmacol Sin; 2023 Oct; 44(10):1948-1961. PubMed ID: 37225849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
    Perfeito R; Cunha-Oliveira T; Rego AC
    Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.
    Liu G; Sgobio C; Gu X; Sun L; Lin X; Yu J; Parisiadou L; Xie C; Sastry N; Ding J; Lohr KM; Miller GW; Mateo Y; Lovinger DM; Cai H
    Hum Mol Genet; 2015 Sep; 24(18):5299-312. PubMed ID: 26123485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased mitochondrial calcium sensitivity and abnormal expression of innate immunity genes precede dopaminergic defects in Pink1-deficient mice.
    Akundi RS; Huang Z; Eason J; Pandya JD; Zhi L; Cass WA; Sullivan PG; Büeler H
    PLoS One; 2011 Jan; 6(1):e16038. PubMed ID: 21249202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.